Sabinsa Achieves USP GMP Audited Status for Three Additional Sites

Three additional Sami-Sabinsa Group Manufacturing units have been audited by the United States Pharmacopeia (USP) and received GMP compliance certificates for the Kunigal unit and the Dobaspet unit, both in Bengaluru, India, and the Hyderabad unit in Telangana state, India. The company’s Nelamangala site in Bengaluru received a USP GMP certificate earlier this year. All four sites are certified Halal by The Islamic Food and Nutrition Council of America (IFANCA) and OK Kosher, with the Kunigal and Hyderabad units NSF-GMP certified as well.

Sabinsa cosmetics

Sabinsa’s Curcumin C3 Complex® Identified as the Most Studied

A retrospective analysis of curcumin research presented a comprehensive look at the vast body of science on the popular extract of turmeric. Curcumin: Total-Scale Analysis of the Scientific Literature by Dr. Atanas G. Atanasov et al, a bibliometric review of literature on curcumin published in the April 2019 edition of the journal, Molecules (2019, 24, 1393), discussed investigations into a range of clinical indications, including Alzheimer’s disease, psoriasis vulgaris, obesity, oral lichen planus, osteoarthritis, inflammation associated with metabolic syndrome, and radiation dermatitis as well as for modulation of human gut microbiome.

Sabinsa cosmetics

Sabinsa Staff Available at Booth # 317

Sabinsa will feature two new patent-protected branded ingredients at New York Society of Cosmetic Chemists (NYSCC) Suppliers’ Day tradeshow May 7 – 8, 2019, at the Jacob K. Javits Convention Center in New York City. This important event attracts science and chemistry research management and staff, purchasing agents, and top management representing major cosmetic giants as well as small and start-up companies.

Sami Labs Peenya

Grant Aids Sami Labs to Test Plant Species and Evaluate Commercial Viability in a Sustainable Manner

The Department of Scientific and Industrial Research (DSIR), under the Government of India’s Ministry of Science and Technology has sanctioned funding to Sabinsa’s parent company Sami Labs for research on “Development and standardization of manufacturing processes for large scale production of valuable secondary metabolites from callus-derived cells of vascular cambial explants of selected woody plant species.”


The Sami-Sabinsa Group’s Nelamangala biotechnology site in Bengaluru, India has been audited by the United States Pharmacopeia (USP) and received a GMP compliance certificate on February 25, 2019.

Sabinsa announces that it has been awarded Japanese Patent Number 6472453, US Patent Number 10085963, and Australian Patent Number 2015351423, entitled “Process and compositions for achieving mammalian energy balance.”

East Windsor, NJ (March 29, 2019) –Sabinsa announces the introduction of LactoSporin®, an ingredient for cosmeceutical products that has antimicrobial, antioxidant, anti-inflammatory, and anti-collagenase properties, shows protective efficacy against UV radiation, environmental pollutants, and prevents microbial biofilm formation, induces hair growth, and prevents accelerated skin aging.


The Sami-Sabinsa Group’s ambitious 10-year reforestation program of Pterocarpus Marsupium trees in India has been chosen as one of two finalists in the NutraIngredients-USA Editors Award for Industry Initiative of the Year. The winner will be announced at an event in Chicago on July 16, 2018.


The Sami-Sabinsa Group, a pioneer in science-backed nutraceutical and cosmeceutical ingredients, was honored last week by two separate awards from two respected industry organizations for the company’s cultivation programs.

Sabinsa is please to announce that Natalie Martinez has joined the company as Head of Cosmetics Sales for the Americas.